The Synthesis of N-Vanillyl-arachidonoyl-amide (ARVANIL (cas 128007-31-8)) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate
-
Add time:08/29/2019 Source:sciencedirect.com
Several arvanil analogs were synthesized where the end n-pentyl chain was branched and carried substituents at the terminal end of the chain. A high yielding total synthesis of these analogs was developed from methyl hex-5-ynoate, which was converted to the synthon 6 in a facile five step sequence (overall yield, 33%). The pharmacological profile of these novel analogs suggests that they may be acting through a novel site of action for anandamide (arachidonylethanolamide, AEA).
We also recommend Trading Suppliers and Manufacturers of ARVANIL (cas 128007-31-8). Pls Click Website Link as below: cas 128007-31-8 suppliers
Prev:ARVANIL (cas 128007-31-8)-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors
Next:Identification of molybdopterin guanine dinucleotide (cas 128007-95-4) in formate dehydrogenase from Methanobacterium formicicum) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ARVANIL (cas 128007-31-8)-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors08/28/2019
- Effect of ARVANIL (cas 128007-31-8) (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide–capsaicin hybrid, on ion currents in NG108-15 neuronal cells08/27/2019
- ARVANIL (cas 128007-31-8) and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells08/26/2019
- Short CommunicationARVANIL (cas 128007-31-8), a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease08/25/2019
- ARVANIL (cas 128007-31-8) inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis08/24/2019
- Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to ARVANIL (cas 128007-31-8), an endocannabinoid and vanilloid hybrid, in rats08/23/2019
- Pulmonary, Gastrointestinal and Urogenital PharmacologyMidcervical vagotomy precludes respiratory response to novel anti-inflammatory and anti-tumour drug ARVANIL (cas 128007-31-8) in rats08/22/2019
- Short communicationARVANIL (cas 128007-31-8), olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice08/21/2019


